Advertisement
Australia markets closed
  • ALL ORDS

    7,861.00
    -1.30 (-0.02%)
     
  • AUD/USD

    0.6424
    +0.0021 (+0.32%)
     
  • ASX 200

    7,605.60
    -6.90 (-0.09%)
     
  • OIL

    84.93
    -0.43 (-0.50%)
     
  • GOLD

    2,393.40
    -14.40 (-0.60%)
     
  • Bitcoin AUD

    99,470.66
    +1,099.69 (+1.12%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

Swiss Prime Site AG (VTX:SPSN) Analysts Are Reducing Their Forecasts For This Year

The analysts covering Swiss Prime Site AG (VTX:SPSN) delivered a dose of negativity to shareholders today, by making a substantial revision to their statutory forecasts for this year. Both revenue and earnings per share (EPS) forecasts went under the knife, suggesting the analysts have soured majorly on the business.

After the downgrade, the consensus from Swiss Prime Site's five analysts is for revenues of CHF617m in 2024, which would reflect a measurable 7.7% decline in sales compared to the last year of performance. Statutory earnings per share are presumed to soar 115% to CHF2.43. Prior to this update, the analysts had been forecasting revenues of CHF695m and earnings per share (EPS) of CHF2.82 in 2024. Indeed, we can see that the analysts are a lot more bearish about Swiss Prime Site's prospects, administering a substantial drop in revenue estimates and slashing their EPS estimates to boot.

See our latest analysis for Swiss Prime Site

earnings-and-revenue-growth
earnings-and-revenue-growth

Analysts made no major changes to their price target of CHF90.83, suggesting the downgrades are not expected to have a long-term impact on Swiss Prime Site's valuation.

ADVERTISEMENT

These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the Swiss Prime Site's past performance and to peers in the same industry. One thing that stands out from these estimates is that shrinking revenues are expected to moderate over the period ending 2024 compared to the historical decline of 15% per annum over the past five years. Compare this against analyst estimates for companies in the broader industry, which suggest that revenues (in aggregate) are expected to decline 5.7% annually. So it's pretty clear that Swiss Prime Site sales are expected to decline at a faster rate than the wider industry.

The Bottom Line

The biggest issue in the new estimates is that analysts have reduced their earnings per share estimates, suggesting business headwinds lay ahead for Swiss Prime Site. Unfortunately they also cut their revenue estimates for this year, and they expect sales to lag the wider market. That said, earnings per share are more important for creating value for shareholders. The lack of change in the price target is puzzling in light of the downgrade but, with a serious decline expected this year, we wouldn't be surprised if investors were a bit wary of Swiss Prime Site.

There might be good reason for analyst bearishness towards Swiss Prime Site, like its declining profit margins. Learn more, and discover the 3 other concerns we've identified, for free on our platform here.

Another way to search for interesting companies that could be reaching an inflection point is to track whether management are buying or selling, with our free list of growing companies that insiders are buying.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.